Phase 2 studies of lenalidomide, subcutaneous bortezomib, and dexamethasone as induction therapy in patients with newly diagnosed multiple myeloma
暂无分享，去创建一个
J. Laubach | P. Richardson | A. Yee | D. O’Keeffe | P. Dowling | M. Cahill | J. Krawczyk | M. O'Dwyer | J. Rosenblatt | G. Bianchi | P. O’Gorman | P. Browne | P. Murphy | P. Hayden | G. Crotty | H. O'leary | Heidi Dipietro | Kristen Cummings | O. Gilligan | K. Scott | C. Tierney | B. Hennessy | Alexandra Savell | M. Perera | Kelly Masone | M. B. John Quinn | T. Guerrero Garcia | K. Saeed | A. Savell | Khalid Saeed | Ciara Tierney | P. O’gorman